This inventor holds 33 USPTO granted patents and 8 published patent applications, plus 10 CIPO patents and 11 EPO patents, primarily in Vaccine Development. Top assignees: Acambis Inc., Hookipa Biotech Gmbh, Sanofi Pasteur Biologics, LLC. Active years: 1997-2023.
Location History:
- Cambridge, MA (US) (1997)
- Harvard, MA (US) (1998 - 2023)
Company Filing History:
10 out of 13 
5 out of 6 
5 out of 24 
Years Active: 1997-2023
Areas of Expertise:
Title: Thomas P. Monath: A Pioneer in Vaccine Innovations
Introduction
Thomas P. Monath, based in Harvard, MA, stands out as a distinguished inventor with an impressive portfolio of 33 patents. His groundbreaking work primarily focuses on innovative vaccines, which are vital in the fight against various viral infections and related diseases.
Latest Patents
Monath's latest contributions to the field include significant patents for vaccines targeting cytomegalovirus (CMV) and human papillomavirus (HPV). The CMV vaccines involve genetically modified arenaviral vectors that are designed for both prevention and treatment of CMV infections and reactivation. The associated pharmaceutical compositions offer promising methods for treating these infections. Similarly, his patents for HPV vaccines feature genetically modified arenaviruses that serve as effective vaccines against neoplastic diseases, particularly those related to oncogenic viruses. These advancements include innovative pharmaceutical compositions and methods for preventing and treating conditions like cervical cancer and other cancers caused by HPV.
Career Highlights
Throughout his illustrious career, Thomas P. Monath has significantly impacted the biopharmaceutical landscape. He has collaborated with renowned organizations, including Acambis Inc. and Hookipa Biotech GmbH, contributing his expertise to advance vaccine technology and microbial therapeutics.
Collaborations
Monath's work has often involved collaboration with talented professionals in the field. Notable colleagues include Farshad Guirakhoo and Juan Arroyo, who, alongside Monath, have made strides toward innovative solutions for public health challenges.
Conclusion
With his vast experience and dedication to scientific exploration, Thomas P. Monath continues to be a leading figure in vaccine innovation. His patents not only illustrate his commitment to combating viral infections but also his role in shaping the future of preventive medicine.